Menu
Click the cover below to view the digital edition of JCAD January 2021.
Dear Editor: There is no doubt now that the use of botulinum toxin (BoNT) in aesthetics has been a revolution for the noninvasive treatment of patients. In the last several decades, the use of BoNT has changed from fixed doses delivered at fixed time intervals into fixed anatomical sites, all of which were required for
J Clin Aesthet Dermatol. 2021;14(1):14–20. by Clinton W. Enos, MD; Soquel Rey, BS; Jayne Slocum, BS; Lauren Green, MPH; and Edward Prodanovic, MD Dr. Enos, Dr. Prodanovic, Mr. Rey, and Ms. Slocum are with the Department of Dermatology, Eastern Virginia Medical School in Norfolk, Virginia. Ms. Green is with the Healthcare Analytics and Delivery Science
J Clin Aesthet Dermatol. 2021;14(1):21–23 by Stephen Ansah-Addo, MD, and Andrew F. Alexis, MD, MPH Mr. Ansah-Addo is with the Albert Einstein College of Medicine in the Bronx, New York, New York. Dr. Alexis is with the Department of Dermatology at Mount Sinai St. Luke’s and Mount Sinai West in New York, New York. FUNDING:
J Clin Aesthet Dermatol. 2021;14(1):24–26. by Bruna Souza Felix Bravo, MD; Camila Roos Mariano da Rocha, MD; Leonardo Gonçalves Bravo, MD; Raquel de Melo Carvalho, MD; and Lucia Joffily, MD Drs. B. S. F. Bravo, Mariano Da Rocha, L. G. Bravo, and De Melo Carvalho are Clínica Bravo in Rio de Janeiro, Brazil. Dr. Joffily
